 | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | |
|||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 3 | |
| Rating ROA | 1 | |
| Rating EQUITY | 2 | |
| Rating ROE | 1 | |
| Rating DER | 4 | |
| Rating TOTAL | 2 | |
| MARKET CAPITALIZATION | ||
| Listed Share | 3.600.000 | |
| Price | Rp. 29.000 | |
| Capitalization | Rp. 104.400.000.000 | |
| OWNERSHIP | ||
| Listing Date : 08-Jun-90 | ||
| Lokal 0,16 % | Asing 98,79 % | Lainnya 1,05 % |
| SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
Financial Statements
| Description | 2Q18 | 2Q19 | 2Q20 | 2Q21 | 2Q22 | 2Q23 | 2Q24 | CAGR 5Y(%) |
| Last Price | 29000 | 29000 | 29000 | 29000 | 29000 | 29000 | 29000 | |
| Market Cap | 104.4 B | 104.4 B | 104.4 B | 104.4 B | 104.4 B | 104.4 B | 104.4 B | |
| BALANCE SHEET | ||||||||
| Cash | 29.6 B | 185.3 B | 27.9 B | 162.9 B | 78.3 B | 302.5 B | 128.0 B | -30.92 |
| Total Asset | 1.6 T | 1.7 T | 1.8 T | 1.6 T | 1.5 T | 1.5 T | 1.7 T | |
| S.T.Borrowing | 800.1 B | 509.9 B | 565.2 B | 616.8 B | 346.3 B | 559.7 B | 670.3 B | |
| L.T.Borrowing | 335.0 B | 616.2 B | 452.9 B | 38.6 B | 35.8 B | 35.4 B | 41.2 B | |
| Total Equity | 471.7 B | 575.0 B | 744.6 B | 924.2 B | 1.1 T | 940.1 B | 952.1 B | 65.58 |
| INCOME STATEMENT | ||||||||
| Revenue | 1.1 T | 812.0 B | 1.3 T | 867.9 B | 1.1 T | 1.2 T | 1.4 T | 72.41 |
| Gross Profit | 175.3 B | 127.2 B | 179.8 B | 125.5 B | 159.6 B | 191.2 B | 169.9 B | 33.57 |
| Operating Profit | 152.3 B | 57.4 B | 160.5 B | 93.6 B | 129.8 B | 171.2 B | 144.4 B | 151.57 |
| Net.Profit | 114.6 B | 72.6 B | 127.6 B | 72.0 B | 104.2 B | 134.7 B | 111.6 B | 53.72 |
| EBITDA | 161.5 B | 67.5 B | 175.0 B | 106.7 B | 142.0 B | 185.8 B | 157.2 B | 132.89 |
| Interest Expense | 8.3 B | 11.6 B | 13.4 B | 3.8 B | 96.7 M | 108.0 M | 83.8 M | |
| RATIO | ||||||||
| EPS | 31823.23 | 20172.76 | 35448.06 | 20013.31 | 28946.79 | 37424.16 | 31002.58 | 53.69 |
| PER | 0.91 x | 1.44 x | 0.82 x | 1.45 x | 1.00 x | 0.77 x | 0.94 x | |
| BVPS | 131031.6 | 159729.79 | 206837.02 | 256728.78 | 299100.26 | 261129 | 264460.25 | |
| PBV | 0.22 x | 0.18 x | 0.14 x | 0.11 x | 0.10 x | 0.11 x | 0.11 x | |
| ROA | 0.0713 | 0.0427 | 0.0724 | 0.0456 | 0.0714 | 0.0878 | 0.0671 | 57.14 |
| ROE | 0.2429 | 0.1263 | 0.1714 | 0.078 | 0.0968 | 0.1433 | 0.1172 | -7.21 |
| EV/EBITDA | 7.49 | 15.48 | 6.25 | 5.59 | 2.87 | 2.14 | 4.37 | |
| Debt/Equity | 2.41 | 1.96 | 1.37 | 0.71 | 0.35 | 0.63 | 0.75 | |
| Debt/TotalCap | 0.71 | 0.66 | 0.58 | 0.41 | 0.26 | 0.39 | 0.43 | |
| Debt/EBITDA | 7.03 | 16.68 | 5.82 | 6.14 | 2.69 | 3.2 | 4.53 | |
| EBITDA/IntExps | 19.53 | 5.82 | 13.03 | 28.02 | 1468.68 | 1720.34 | 1875.7 | 32128.52 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | |
|||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| MARKET CAPITALIZATION | ||
| Listed Share | 3.600.000 | |
| Price | Rp. 29.000 | |
| Capitalization | Rp. 104 B. | |
| OWNERSHIP | ||
| Listing Date : 08-Jun-90 | ||
| Lokal 0,16 % | Asing 98,79 % | Lainnya 1,05 % |
| RATING FUNDAMENTAL | ||
|---|---|---|
| Rating EPS | 3 | |
| Rating ROA | 1 | |
| Rating EQUITY | 2 | |
| Rating ROE | 1 | |
| Rating DER | 4 | |
| Rating TOTAL | 2 | |
EARNING PER SHARE
| SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | SCPI - Organon Pharma Indonesia Tbk. | |
| Sector | : | Healthcare | ||
| Sub Sector | : | Pharmaceuticals and Health Care Research | ||
| Industry | : | Pharmaceuticals | ||
| Sub Industry | : | Pharmaceuticals | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Index (4) | : | COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Board | : | 4 Index COMPOSITE, IDXHEALTH, ISSI, DBX | ||
| Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
| Corporate Action | : | - | ||
| Special Notation | : | Perusahaan Tercatat memenuhi kriteria Efek Bersifat Ekuitas Dalam Pemantauan Khusus. | ||
| TIME PERIOD : 29-11-2024 | |||
| Close | 29000 | Prev Close | 29000 |
| Change | - | Range | 0-0 |
| Bid | 0 | Offer | 0 |
| Bid Volume | 0 | Offer Volume | 0 |
| Frequency | 0 | Value Rp.: 0 | |
| EARNING PER SHARE (% PRICE) | |||||
|---|---|---|---|---|---|
| Benchmark to Others : | |||||
| A Exceptional | |||||
| B Excellent | |||||
| C Very Good | |||||
| D Good | |
||||
| E Fair | |||||
| F Poor | |||||
| Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
| RATING & BTO MATRIX | ||||||
|---|---|---|---|---|---|---|
| Benchmark to Others : | ||||||
| A Exceptional | ||||||
| B Excellent | ||||||
| C Very Good | ||||||
| D Good | |
|||||
| E Fair | ||||||
| F Poor | ||||||
| RATING | ||||||
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |
| RATING | 0 | 1 | 2 | 3 | 4 | 5 |